Pfizer Asks Court To Keep Purepac’s Neurontin Generic Off The Market
This article was originally published in The Pink Sheet Daily
Executive Summary
Brand company’s arguments in support of a preliminary injunction could be bolstered by the fact that, unlike Ivax’ product, Purepac’s gabapentin generic is AB-rated and the Alpharma division has said a launch would not hinge on resolution of patent litigation with Pfizer.